Quote of the Month
Karl Friston | | Quick Read
There is a pressing need for data that constrains our uncertainty about the current level of prevalent immunity. We need serological testing – not necessarily massively large-scale, but certainly sufficient to get a handle on how many people have had COVID-19 in the past few weeks. What proportion of people have had the infection and will have therefore a reduced probability of being reinfected? That’s an incredibly important unknown.
– Karl Friston, Wellcome Principal Research Fellow and Scientific Director at the Wellcome Trust Centre for Neuroimaging; Professor at the Institute of Neurology, University College London; and Honorary Consultant at the National Hospital for Neurology and Neurosurgery, London, UK
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Pathologist site. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.